Prof. Dr. Esin AKI-YALÇIN’ nın ÖZGEÇMİŞ BİLGİLERİ Önceki Soyadı: (Şener)

E-posta: esinaki@ankara.edu.tr Web-sayfası: http://kisisel.ankara.edu.tr/ankara.edu.tr/esinaki/ http://www.esisresearch.org Öğrenim Durumu: 1966-1973 : TED Ankara Koleji 1974-1978 : Gazi Üniversitesi, Eczacılık Fakültesi 1979-1986 : Ankara Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalı Asistan Kadrosu 1983 : Doktora derecesi 1986 - 1988 : Ankara Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalı Yardımcı Doçentlik kadrosu 1987 : Doçentlik derecesi 1988 - 1993 : Ankara Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Doçentlik kadrosu 1993- : Profesörlük kadrosu Yönetsel Görevleri: 1999 -2002 : Ankara Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalı Başkanlık Görevi 2003- 2006 : Ankara Üniversitesi, Eczacılık Fakültesi, Meslek Bilimleri Bölüm Başkanlığı 2008-2009 : Ankara Üniversitesi, Eczacılık Fakültesi Dekan Vekili 2009-2012 : Ankara Üniversitesi Rektör Danışmanlığı Bilimsel Dernek Başkanlığı: 2007-2009 : Bilgisayar Destekli İlaç Tasarım ve Geliştirme Derneği

(CADDD&D Society in Turkey) Kurul Üyelikleri: Yurtdışı:

Çalışma Adresi: Ankara Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalı Tandoğan, TR-06100 Ankara İş Tel: (312) 223 69 40 Faks: (312) 223 69 40 GSM: (532) 337 31 11

2004- : “International QSAR and Chemoinformatics” Member of Chairs’ Board) 2004-2009 : “International QSAR and Chemoinformatics” Executive Committee

member 2006-2008 : “Asian Federation of Medicinal Chemistry “ Executive Committee

member, General Secretary 2008- : “Asian Federation of Medicinal Chemistry” Avrupa Temsilciliği

Yurtiçi: 1997 – 2000 : Ankara Üniversitesi Eczacılık Fakültesi Fakültesi Yönetim Kurulu

Üyeliği 1992-1993 : Ankara Üniversitesi Eczacılık Fakültesi Fakülte Kurul Üyeliği 2003- 2006 : Ankara Üniversitesi Eczacılık Fakültesi Fakülte Kurul Üyeliği 2002-2003 : Ankara Üniversitesi Biyoteknoloji Enstitüsü Danışma Kurul Üyeliği 2003- : Ankara Üniversitesi Biyoteknoloji Enstitüsü Proje Değerlendirme 1994- 1998 : Medisinal ve Farmasötik Kimya Derneği Yönetim Kurul üyesi 1997- 2000 : Ankara Üniversitesi Mezunları Derneği Yönetim Kurul üyesi

Düzenlediği Uluslararası Kongre ve Toplantı Başkanlıkları:

1. 15th European Symposium on Quantitative Structure-Activity Relationships”, İstanbul, Turkey, 05-10 September 2004 (Organizasyon Komitesi Başkanı)

2. 6th AFMC Medicinal Chemistry Symposium, Istanbul, Turkey, 08-11 July 2007 (Organizasyon Komitesi Başkanı)

3. Workshop on Computer Aided Drug Design & Development, 02-05 Feb 2007, Istanbul, Turkey (Organizasyon Komitesi Başkanı)

4. 5th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources”, 04-08 July 2009, Istanbul, Turkey (Organizasyon Komitesi Başkanı)

Aldığı Patent: DE102008027361: Kiessig Stephan [DE];Rockensuess Klaus-Dieter [DE],Varga Andras[DE],Molnar Josef[DE],Cherepnev Georgy [RU], AKI Esin[TR], YALCIN İsmail[TR],Lage Hermann[DE], Amaral Leonard[US], “Composition useful e.g. for the chemosensibilizing and simultaneous apoptosis induction of multidrug resistance of tumor” 10.11.2009. Ödülleri: 1.International Scientific Partnership Foundation Medal “Badge of Honor" 2. International Scientific Partnership Foundation Honourable Diploma of ISPF. 3. “Asian Federation of Medicinal Chemistry” Fellowship diploma Bilimsel Dergi Yayın Kurul Üyelikleri: Yurtdışı: 2004- : ARKIVOC Journal of Organic Chemistry 2004- : Current Computer Aided Drug Design Journal Yurtiçi:

2001- : Ankara Üniversitesi Eczacılık Fakültesi Dergisi (Yurtiçi) Dernek Üyelikleri: Yurtdışı: 1992- : International QSAR and Chemoinformatic Society 2002- : American Chemical Society 2005- : Asian Federation of Medicinal Chemistry Yurtiçi: 1994- : Medisinal ve Farmasötik Kimya Derneği (Kurucu üye) 1998- : Ankara Üniversitesi Mezunları Derneği 2004-2007 : Bilgisayar Destekli İlaç Tasarım ve Geliştirme Derneği

(CADDD&D Society in Turkey) (Kurucu üye, 2. Başkan) 1982- : Farmasötik Bilimler Ankara Derneği (FABAD) 1998- : Ankara Üniversitesi Eczacılık Fakültesi Geliştirme Derneği

Yurtdışı Projeleri:

1. Avrupa Birliği 5. Çerçeve Kapsamında COST ACTION B16, 2002-2005. 2. Macaristan-Türkiye Hükümetleri İşbirliği Projesi 2004-2006. 3. 2001 K-120-240(110) Ankara Üniversitesi Biyoteknoloji Enstitüsü Projesi

(Emory Üniversitesi, Atlanta, USA ile birlikte oluşturulmuştur), 2003- 2006. 4. Avrupa Birliği 6. Çerçeve Kapsamında COST ACTION BM0701 ATENS

2008-2013.

PROF. DR. ESİN AKI-YALÇIN’ IN YAYIN LİSTESİ (Kullandığı soyadları: ŞENER, AKI, YALÇIN)

A- ÖZGÜN YAYINLARI A. 1. YURT DIŞI DERGİLERDE YAYINLANANLAR A.1.1. SCI ve SCI Expanded KAYITLI DERGİLERDE YAYINLANANLAR: [1] YALÇIN, İ., ŞENER, E., ÖZDEN, T., ÖZDEN, S., AKIN, A., Synthesis and

Microbiological Activity of 5-Metyl-2-(p-substitutedphenyl)benzoxazoles, European Journal of Medicinal Chemistry, 25, 705-708 (1990).

[2] ŞENER. E., YALÇIN, İ., SUNGUR, E., QSAR of Some Antifungal Benzoxazoles and Oxazolo (4,5-b)pyridines Against C. albicans, Quantitative Structure-Activity Relationships, 10, 223-228 (1991).

[3] YALÇIN, İ., ÖREN, İ., ŞENER, E., AKIN, A., UÇARTÜRK, N., The Synthesis and the Structure- Activity Relationships of Some Substituted Benzoxazoles, Oxazolo(4,5-b)pyridines, Benzothiazoles and Benzimidazoles as Antimicrobial Agents, European Journal of Medicinal Chemistry, 27, 401-406 (1992).

[4] YALÇIN, İ., ŞENER, E., QSARs of Some Novel Antibacterial Benzimidazoles, Benzoxazoles and Oxazolopyridines Against an Enteric Gram-negative Rod, International Journal of Pharmaceutics, 98, 1-8 (1993).

[5] ŞENER, E., TURGUT,H., YALÇIN, İ., ÖREN, İ., TÜRKER, L., ÇELEBİ, N., AKIN, A., Structure-Activity Relationships of Some Antimicrobial 5-Substituted-2-(3-pyridyl)benzoxazoles Using Quantum Chemical Calculations, International Journal of Pharmaceutics, 110, 109-115 (1994).

[6] ŞENER, E., YALÇIN, İ., TEMİZ, Ö., ÖREN, İ., AKIN, A. AND UÇARTÜRK, N. “Synthesis and Structure-Activity Relationships of Some 2,5-Disubstitured Benzoxazoles and Benzimidazoles as Antimicrobial Agents”, Il Farmaco, 52(2), 99-103 (1997).

[7] ÖREN, İ., TEMİZ, Ö., YALÇIN, İ., ŞENER, E., AKIN, A. AND UÇARTÜRK, N. “Synthesis and Microbiological Activity of 5(or 6)-Methyl-2-substituted Benzoxazole and Benzimidazole Derivatives”, Arzneim-Forsch./Drug Res., 47(12), 1393-1397 (1997).

[8] YALÇIN, İ., KAYMAKÇIOĞLU, B. K., ÖREN, İ., ŞENER, E., TEMİZ, Ö., AKIN, A. AND ALTANLAR, N., “Synthesis and Microbiological Activity of Some Novel N-(2-Hydroxyl-5-substitutedphenyl)benzacetamides, Phenoxyacetamides and Thiophenoxyacetamides as The Possible Metabolites of Antimicrobial Active Benzoxazoles”, Il Farmaco, 52(11), 685-689 (1997).

[9] TEMİZ, Ö., ÖREN, İ., ŞENER, E., YALÇIN, İ. AND UÇARTÜRK, N., “Synthesis and Microbiological Activity of Some Novel 5- or 6-Methyl-2-(2,4-disubstituted phenyl)benzoxazole Derivatives”, Il Farmaco, 53, 337-341 (1998).

[10] ÖREN, İ., TEMİZ, Ö., YALÇIN, İ., ŞENER, E. AND ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some Novel 2, 5- and/or 6-Substituted Benzoxazole and Benzimidazole Derivatives”, European Journal of Pharmaceutical Sciences, 7, 153-160 (1998).

[11] MROZEK, A., KAROLAK-WOICIECHOWSKA, J., YALÇIN, İ., ŞENER, E., “Crystal Structure of 2-(2-Cyclohexyl)ethyl benzimidazole”, Z. Kristallogr. NCS, 214, 181-182 (1999).

[12] MROZEK, A., TRZEZWINSKA, H., KAROLAK-WOICIECHOWSKA, J., YALÇIN İ., ŞENER, E., “Molecular Structure of 5-Chloro-2-(p-t-butylphenyl)benzoxazole. Relation Between Structure and Antimicrobial Activity of 2,5-Disubstituted Benzoxazoles”, Polish J. Chem., 73, 625-633 (1999).

[13] ŞENER, E.A., ARPACI-TEMİZ, Ö., YALÇIN, İ., ALTANLAR, N.; “Synthesis and microbiological activity of some novel 5-benzamido- and 5-phenylacetamido- substituted 2-phenylbenzoxazole derivatives” Il Farmaco, 55, 397-405 (2000) .

[14] YALÇIN, İ., ÖREN, İ., TEMİZ, Ö., ŞENER, E.A.; “QSARs of some novel isosteric heterocyclics with antifungal activity” Acta Biochimica Polonica, 47 (2), 481-486 (2000).

[15] ŞENER, E.A., BİNGÖL, K.K., ÖREN, İ., TEMİZ-ARPACI, Ö., YALÇIN, İ., ALTANLAR, N.: “Synthesis and microbiological activity of some N-(o-hydroxyphenylbenzmides and phenylacetamides as the possible metabolites of antimicrobial active benzoxazoles, Part II.”, Il Farmaco, 55, 469-476 (2000).

[16] R. CZYLKOWSKİ, J. KAROLAK-WOJCİECHOWSKA, YALÇIN, İ., ŞENER, E.A., “Structure and Conformational Preferences of 2-Substituted-benzoxazoles”, J. Mol. Structure, 598(2-3), 197-205, 2001.

[17] AKI-ŞENER, E., BİNGÖL, K.K., TEMİZ-ARPACI, Ö., YALÇIN, İ., ALTANLAR, N, “Synthesis and microbiological activity of some N-(2-hydroxy-4-substitutedphenyl)benzamides, phenylacetamides and furamides as the possible

metabolites of antimicrobial active benzoxazoles”, Il Farmaco, 57, 451-456, (2002).

[18] TEMİZ-ARPACI, Ö, AKI-ŞENER, E., YALÇIN, İ., ALTANLAR, N., “Synthesis and microbiological activity of some novel N-[2-(p-substitutedphenyl)-5-benzoxazolyl]-cyclohexyl carboxamide, -cyclohexyl acetamide and –cyclohexyl propionamide derivatives”, Il Farmaco, 57, 771-775, (2002).

[19] TEMİZ-ARPACI, Ö., AKI-ŞENER E., YALÇIN, İ., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 2-(p-substituted-phenyl)benzoxazol-5-yl-arylcarboxamides”, Arch. Pharm. Pharm. Med. Chem, 6, 283-288, (2002).

[20] AKBAY, A., ÖREN, İ., TEMİZ-ARPACI, Ö., AKI-ŞENER, E., YALÇIN, İ., “Synthesis and HIV-1 Reverse Transcriptase Inhibitor Activity of Some 2,5,6-Substituted Benzoxazole, Benzimidazole, Benzothiazole and Oxazolo(4,5-b)pyridine Derivatives”, Arzneim-Forsch./Drug Res., 53 (4), 266-271, (2003).

[21] YALÇIN, İ., TEKİNER; B. P., ÖREN-YILDIZ, İ., TEMİZ-ARPACI, Ö., AKI-ŞENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some Novel 2,6,7-trisubstituted-2H-3,4-dihydro-1,4-benzoxazin-3-one Derivatives”, Indian Journal of Chemistry, 42B, 905-909, (2003).

[22] ALPER, S., TEMİZ-ARPACI, Ö., AKI-ŞENER, E., YALÇIN, İ.,”Some New bi-and ter-benzimidazole Derivatives as Topoisomerase I Inhibitors”, Il Farmaco, 58, 497-507, (2003).

[23] YILDIZ-ÖREN, i., AKI-ŞENER, E., ERTAŞ, C., TEMİZ-ARPACI, Ö., YALÇIN, İ., ALTANLAR, N., “Synthesis and Microbiological activity of Some Substituted N-(2-hydroxy-4-nitrophenyl)benzamides, phenylacetamides as Possible Metabolites of Antimicrobial Active Benzoxazoles”, Turk J Chem., 28, 441-449, (2004).

[24] PINAR, A., YURDAKUL, P., YILDIZ, İ., TEMİZ-ARPACI, Ö., AÇAN, N.L., AKI-ŞENER, E., YALÇIN, İ.,”Some Fused Heterocyclic Compounds as Eukaryotic Topoisomerase II Inhibitors”, Biochemical and Biophysical Research Communications, 317, 670-674, (2004).

[25] ÖREN-YILDIZ, İ., YALÇIN, İ., AKI-ŞENER E., ALTANLAR, N., “Synthesis and Structure-Activity Relationships of New Antimicrobial Active Multisubstituted Benzoxazole Derivatives”, European Journal of Medicinal Chemistry, 39, 291-298, (2004).

[26] PLEMPER, R.K., ERLANDSON, K.J., LAKDAWALA, A.S., SUN, A., PRUSSIA, A., BOONSOMBAT, J., AKI-ŞENER E., YALÇIN, İ., YILDIZ, İ., TEMİZ-ARPACI, Ö., TEKİNER; B. P., LIOTTA, D., SNYDER, J.P., COMPANS, R.W., “A Target Site for Template-Based Design of Measles Virus Entry Inhibitors”, PNAS, 101(15), 5628-5633, (2004).

[27] ÖREN-YILDIZ, İ., TEKİNER-GULBAŞ; B. P., YALÇIN, İ., TEMİZ-ARPACI, Ö., AKI-ŞENER E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of New 2-[p-Substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles”, Arch. Pharm. Pharm. Med. Chem, 337, 402-410, (2004).

[28] TEMİZ-ARPACI, O., ÖZDEMİR, A., YALÇIN, İ., YILDIZ, İ., AKI-ŞENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 5-[2-(Morpholin-4-yl)acetamido] and/or 5-[2-(4-Substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl)benzoxazoles, Arch. Pharm. Chem. Life Sci., 338, 105-111, (2005).

[29] TEMİZ-ARPACI, O, TEKINER-GULBAS, B., YILDIZ, İ., AKI-ŞENER, E., YALÇIN, İ., “3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular .field analysis method” Bioorganic & Medicinal Chemistry, (2005), 13, 6354–6359.

[30] VARGA, A., AKI-SENER, E., YALCIN, I., TEMIZ-ARPACI, O., TEKINER-

GULBAS, B., CHEREPNEV, G., MOLNAR, J., “Induction of Apoptosis and Necrosis by Resistance Benzazoles and Benzoxazines on Tumour Cell Line Mouse Lymphoma L5718 Mdr+cells” In vivo, 19, 1087-1092, (2005).

[31] LAGE, H., TEKINER-GULBAS, B., TEMIZ-ARPACI, O., AKI-SENER, E., YALCIN, I., “High antineoplastic activity of heterocyclic DNA topoisomerase II inhibitors in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs and structure-activity relationships”, Int. J. Cancer., 119, 213-220, 2006.

[32] TEKINER-GULBAS, B., TEMIZ-ARPACI, O., YILDIZ, I., AKI-SENER, E., YALCIN, I., “3-D-QSAR Study on Heterocyclic Topoisomerase II Inhibitors Using CoMSIA”, SAR and QSAR in Enviromental Research, 17(2), 1-12, 2006.

[33] TEMIZ-ARPACI, O., COBAN, T., TEKINER-GULBAS, B., CAN-EKE, B., YILDIZ, İ., AKI-SENER, E., YALCIN, I., ISCAN, M., “A Study on the Antioxidant Activties of Some New Benzazole Derivatives”, Acta Biol. Hungarica, 57 (2), 201-209, 2006.

[34] ALPER-HAYTA, S., AKI-SENER, E., TEKINER-GULBAS, B., YILDIZ, İ., TEMIZ-ARPACI, O., YALCIN, I., ALTANLAR, N., “Synthesis, Antimicrobial Activity and QSARs of New Benzoxazine-3-ones”, Eur. J. Med. Chem., 41, 1398-1404, 2006.

[35] TEKINER-GULBAS, B., TEMIZ-ARPACI, O., YILDIZ, I., AKI-SENER, E., YALCIN, I., “3D-QSAR Study on Heterocyclic Topoisomerase II Inhibitors using CoMSIA”, SAR and QSAR in Enviromental Research, 17(2), 121-132, (2006).

[36] OKSUZOGLU, E., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., EROGLU, H., SEN, G., ALPER, S., YILDIZ, I., DIRIL, N., AKI-SENER, E., YALCIN, I., "A Study on the Genotoxic Activities of Some New Benzoxazoles", Medicinal Chemistry Research, 16, 1–14, (2007).

[37] OKSUZOGLU, E., TEKINER-GULBAS, B., ALPER, S., TEMIZ-ARPACI, O., ERTAN, T., YILDIZ, I., DIRIL, N., SENER-AKI, E., YALCIN, I., "Some Benzoxazoles and Benzimidazoles as DNA Topoisomerase I and II Inhibitors", Journal of Enzyme Inhibition and Medicinal Chemistry, 23, 37-42, (2007).

[38] TEKINER-GULBAS, B., TEMIZ-ARPACI, O., OKSUZOGLU, E., EROGLU, H., YILDIZ, I., DIRIL, N., AKI-SENER, E., YALCIN, I., "QSAR of Genotoxic Active Benzazoles", SAR and QSAR in Environmental Research, 18, 251–263, (2007).

[39] MARTINS, M., SCHELZ, Z., MARTINS, A., MOLNAR, J., HAJÖS, G., RIEDL, Z., VIVEIROS, M., YALCIN, I., AKI-SENER, E., AMARAL, L., "In Vitro and Ex Vivo Activity of Thioridazine Derivatives against Mycobacterium tuberculosis", International Journal of Antimicrobial Agents, 29, 338–340, (2007).

[40] ERTAN, T., YILDIZ, I., OZKAN, S., TEMIZ-ARPACI, O., KAYNAK, F., YALCIN, I., AKI-SENER, E., ABBASOGLU, U., "Synthesis and Biological Evaluation of New n-(2-Hydroxy-4(or 5)-nitro/ aminophenyl)benzamides and

Phenylacetamides as Antimicrobial Agents", Bioorganic and Medicinal Chemistry, 15, 2032-2044, (2007).

[41] KAROLAK-WOJCIECHOWSKA, J., MROZEK, A., CZYLKOWSKI, R., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., "Five-membered heterocycles. Part IV: Impact of heteroatom on benzazole aromaticity", Journal of Molecular Structure, 839, 125-131, (2007).

[42] YILDIZ, I., ERTAN, T., BOLELLI, K., TEMIZ-ARPACI, O.,YALCIN, I. AKI, E., "QSAR and Pharmacophore Analysis on Amides against Drug-Resistant S. aureus", SAR and QSAR in Environmental Research, 19, 101-113, (2008).

[43] ARISOY, M., TEMIZ-ARPACI, O., YILDIZ, I., KAYNAK-ONURDAG, F., AKI, E., YALCIN, I., ABBASOGLU, U., "Synthesis, Antimicrobial Activity and QSAR Studies of 2,5-Disubstituted Benzoxazoles", SAR and QSAR in Environmental Research, 19:5, 589-612, (2008).

[44] TEKINER-GULBAS, B., FILAK, L., VASKO, G.A., EGYED, O., YALÇIN, I., AKI-SENER, E., RIEDL, Z., HAJOS, G., "Synthesis of Novel Pyrazolo[5,1-b][1,3]benzothiazoles: a New Pericyclic Pathway", Heterocycles, 75, 2005-2012, (2008).

[45] TEMIZ-ARPACI, O.,YILDIZ, I., ÖZKAN, S., KAYNAK, F., AKI-ŞENER, E., YALÇIN, I., "Synthesis and Biological Activity of Some New Benzoxazoles", European Journal of Medicinal Chemistry, 43, 1423-1431, (2008).

[46] ALPER-HAYTA, S., ARISOY, M., TEMIZ-ARPACI, Ö., YILDIZ, I., AKI, E., ÖZKAN, S., KAYNAK, F., "Synthesis, Antimicrobial Activity, Pharmacophore Analysis of Some New 2-(Substitutedphenyl/ benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles", European Journal of Medicinal Chemistry, 43, 2568-2578, (2008).

[47] FILAK, L., TEKINER-GULBAS,B., RIEDL, Z., VASKÓ, G.A., EGYED,O., YALÇIN, I., AKI, E., HAJÓS, G., “Ring Expansion of N-Aminobenzothiazolium Salts to Benzothiazines and Benzothiadiazines” Acta Chim. Slov., 56, 622–628, (2009).

[48] ERTAN, T., YILDIZ, I., TEKINER-GULBAS, B., BOLELLI, K., TEMIZ-ARPACI, O., OZKAN, S., KAYNAK, F., YALCIN, I., AKI, E., “Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents”, European Journal of Medicinal Chemistry, 44, 501–510, (2009).

[49] ZEYBEK, B., DURMUS, Z., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., KILIC, E., “Electrochemical Behaviors and Determinations of Some 2,5-Disubstituted Benzoxazole Compoumds at the HAnging Mercury Drop Electrode”, Current Pharm. Analysis, 5, 21-27, (2009).

[50] AKI, E., YALCIN, I., YILDIZ, I., TEMIZ-ARPACI, O., BOLELLI, K., ERTAN-BOLELLI, T., “DNA-Topoisomerase Inhibitory Activity of Some Heterocyclic Compounds and Their Structure-Activity Relationships”, Medicinal Chemistry Research, 19 (Suppl. 1), S6, (2010).

[51] YALCIN, I., AKI, E., YILDIZ, O., TEMIZ-ARPACI, O., “Antimicrobial Activity and Structure-Activity Relationships of Some Synthesized Benzazoles and Their Possible Metabolites”, Medicinal Chemistry Research, 19 (Suppl. 1), S41, (2010).

[52] TASKIN,T., YILMAZ, S., YILDIZ, I. YALCIN, I., AKI, E., “Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cell lines by molecular docking” SAR and QSAR in Environmental Research ,. 23( 3–4), 345–355 (2012).

[53] BOLELLI, K., YALCIN, I., ERTAN-BOLELLI, T., ÖZGEN, S., KAYNAK-ONURDAG, F., YILDIZ, I., AKI, E.” Synthesis of novel 2-[4-(4-substituttedbenzamido/phenylacetamido)phenyl] benzothiazoles as antimicrobial agents” Med. Chem. Res. 21:3818–3825 (2012).

[54] YILMAZ, S., YALCIN, I., KAYNAK-ONURDAG, F., OZGEN, S., YILDIZ, I., AKI, E., Synthesis and In vitro Antimicrobial Activity of Novel 2-(4-(Substituted-carboxamido)benzyl / phenyl)benzothiazoles, Croatica Chemical Acta, 86(2), 223-231, 2013.

[55] BHAGYASREE, J.B., VARGHESE, H.T., PANICKER, C.Y., SAMUEL, J., VAN ALSENOY, C., BOLELLI, K., YILDIZ, I., AKI, E, Vibrational spectroscopic (FT-IR, FT-Raman, 1H NMR and UV) investigations and computational study of 5-nitro-2-(4-nitrobenzyl) benzoxazole Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy 102, 99-113, 2013.

[56] BHAGYASREE, J.B., VARGHESE, H.T.,YOHANNAN PANICKER, C., SAMUEL, J., VAN ALSENOY, C., YILMAZ, S., YILDIZ, I., AKI, E. Quantum mechanical and spectroscopic (FT-IR, FT-Raman, 1H NMR and UV) investigations of 2-(p-nitrobenzyl) benzoxazole , Journal of Molecular Structure 1046 , 92-100, 2013.

[57] KAPLAN-OZEN, C., TEKINER-GULBAS, B., FOTO, E., YILDIZ, I., DIRIL, N., AKI, E., YALCIN, I., "Benzothiazole derivatives as human DNA topoizomerase IIα inhibitors", Med. Chem. Res., 22(12), 5798-5808, (2013).

[58] AKI-YALCIN, E., ERTAN-BOLELLI, T., TASKIN-TOK, T., OZTURK, O., ATAEI, S., OZEN, C., YILDIZ, I., YALCIN, I., "Evaluation of Inhibitory Effects of Benzothiazole and 3-Amino-benzothiazolium Derivatives on DNA Topoisomerase II by Molecular Modeling Studies", SAR and QSAR in Environmental Research, 25(8), 637-649, (2014). doi:10.1080/1062936X.2014.923039.

[59] ERTAN-BOLELLI, T., MUSDAL, Y., BOLELLI, K., YILMAZ, S., AKSOY, Y., YILDIZ, I., AKI-YALCIN, E., YALCIN, I., “Synthesis, Biological Evaluation of 2-Substituted-5-(4-nitrophenylsulfonamido) benzoxazoles as Human GST P1-1 Inhibitors and Description of the Binding Site Features”, ChemMedChem,9(5), 984-992, (2014). doi:10.1002/cmdc.201400010.

[60] YILMAZ, S., ALTINKANAT-GELMEZ, G., BOLELLI, K., GUNESER-MERDAN, D., OVER-HASDEMIR, M. U., YILDIZ, I., AKI-YALCIN, E., YALCIN, I., “Pharmacophore Generation of 2-Substituted Benzothiazoles as AdeABC Efflux Pump Inhibitors in A. baumannii”, SAR and QSAR in Environmental Research, 25(7), 551-563, (2014). doi:10.1080/1062936X.2014.919357 .

[61] ZILIFDAR, F., ALPER-HAYTA, S., YILMAZ, S., KAPLAN-OZEN, C., FOTO, E., AYDOGAN, Z., YILDIZ, I., AKI, E., YALCIN, I., DIRIL, N., "Genotoxic potentials and eukaryotic DNA topoisomerase I inhibitory effects of some benzoxazine derivatives", Med. Chem. Res., 23(1), 480-486, (2014).

[62] SERAP YILMAZ, GULSEN ALTINKANAT-GELMEZ, KAYHAN BOLELLI, DENIZ GUNESER-MERDAN, M. UFUK OVER-HASDEMIR, ESIN AKI-YALCIN, ISMAIL YALCIN, "Binding Site Feature Description of 2-Substituted

Benzothiazoles as AcrAB-TolC Efflux Pump Inhibitors in E. coli", SAR and QSAR in Environmental Research, 1-25 (2015). DOI:10.1080/1062936X.2015.1106581.

[63] ANDRY NUR HIDAYAT, ESIN AKI-YALCIN, MERAL BEKSAC, ERMING TIAN, SAAD Z. USMANI, TUGBA ERTAN-BOLELLI, ISMAIL YALCIN, "Insight into Human Protease Activated Receptor-1 as Anticancer Target by Molecular Modeling", SAR and QSAR in Environmental Research, 1-23 (2015). DOI:10.1080/1062936X.2015.1095799.

[64] TUGBA ERTAN-BOLELLİ, KAYHAN BOLELLİ, SUZAN OKTEN, FATMA KAYNAK-ONURDAG, ESİN AKİ-YALCİN, ISMAİL YALCİN, "Synthesis, Antimicrobial Activities of New Sulfonamidobenzoxazoles and Molecular Docking Studies on Escherichia coli TEM-1 β-Lactamase", Croatica Chemica Acta, 90(1), 67-74 (2017). DOI: 10.5562/cca3111.

[65] TUGBA ERTAN-BOLELLİ*, KAYHAN BOLELLİ, YAMAN MUSDAL, ILKAY YİLDİZ, ESİN AKİ-YALCİN, BENGT MANNERVİK, ISMAİL YALCİN, "Design and synthesis of 2-substituted-5-(4-trifluoromethylphenylsulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors", Artificial Cells, Nanomedicine, and Biotechnology, 45, 1-8 (2017). Doi: 10.1080/21691401.2017.1324464.

A.1. 2. YURT DIŞI HAKEMLİ DERGİ ve KİTAPLARDA YAYINLANANLAR: [66] TÜRKER, L., ŞENER, E., YALÇIN, İ., AKBULUT, U., KAYALIDERE, İ.,

QSAR of Some Antifungal Active Benzoxazoles Using The Quantum Chemical Parameters, Scientica Pharmaceutica, 58, 107-113 (1990).

[67] YALÇIN, İ., ŞENER, E. and ÖREN, İ., QSAR of some antibacterial active isosteric heterocyclic compounds against an enterobacter. In Wermuth, C. G. (Ed.) Trends in QSAR and Molecular Modelling 92. Escom, Leiden, pp. 570-572 (1993).

[68] GÜLLÜ, M., YALÇIN, İ., ŞENER, E., TÜRKER, L., ÇELEBİ, N., AKBULUT, U., Relationships Between Cathodic Peak Potentials and Theoretically Calculated LUMO Energies of Some 2-Phenybenzoxazole Derivatives, Bulletin Soc. Chim. Belg, 103(3), 87-90 (1994).

[69] YALÇIN, İ., ŞENER, E., ÖREN, İ. AND TEMİZ, Ö., Determination of the activity contributions of some novel isosteric heterocyclics against an enteric gram-negative rod using the Free-Wilson analysis. In Sans, F., Giraldo, J. and Manaut, F. (Eds.) QSAR and Molecular Modelling:Concepts, Computational Tools and Biological Applications. Prous, Barcelona, pp. 147-151 (1995).

[70] TÜRKER, L., GÜLLÜ, M., YALÇIN, İ., ŞENER, E., ÇELEBİ, N., Relationships Between Theoretically Calculated LUMO Energies and Cathodic Peak Potentials of Some 2-Benzylbenzoxazole Derivatives, Bulletin Soc Chim. Belg, 105 (6), 303-306 (1996).

[71] TEMİZ-ARPACI, Ö., TEKINER-GULBAS, B., YILDIZ, İ., AKI-ŞENER, E., YALCIN, İ., "3D-QSAR Analysis on Benzazole Derivatives as Eukaryotic Topoisomerase II Inhibitors by using Comparative Molecular Field Analysis

Method", QSAR and Molecular Modelling in Rational Design of Bioactive Molecules, Istanbul-Turkey, September 5-10, 2004, AKI-ŞENER, E., YALÇIN, İ. (Eds.), Başkent Publishing, Ankara, (2006).

A. 2. YURT İÇİ HAKEMLİ DERGİLERDE YAYINLANANLAR [72] NOYANALPAN, N., ŞENER, E., 2-(p-Sübstitüebenzil)benzoksazol

Türevlerinin Sentez, Yapı Aydınlatması ve Antihistaminik Etkileri, FABAD Farmasötik Bilimler Dergisi, 10(4), 275-286 (1985).

[73] YALÇIN, İ., ŞENER, E., ÖZDEN, T., 2-(p-Sübstitüefenil)oksazolo (4,5-b)piridin Türevlerinin Sentez ve Yapı Açıklamaları, Ankara Üniversitesi Eczacılık Fakültesi Dergisi, 15(1), 67-78 (1985).

[74] NOYANALPAN, N., ŞENER,.E., 5-Kloro-2-(p-Sübstitüebenzil)benzoksazol Türevlerinin Sentez ve Yapı Aydınlatması ve Antihistaminik Etkileri, FABAD Farmasötik Bilimler Dergisi, 11(1), 22-30 (1986).

[75] NOYANALPAN, N., ŞENER, E., 5-Nitro-2-(p-Sübstitüebenzil)benzoksazol Türevlerinin Sentez ve Yapı Aydınlatması ve Antihistaminik Etkileri, FABAD Farmasötik Bilimler Dergisi, 11(2), 111-119 (1986).

[76] YALÇIN, İ., ŞENER, E., ÖZDEN, T., 2-(p-Sübstitüefenil)oksazolo (4,5-b)piridin Türevlerinin Sentez ve Yapı Açıklamaları, Ankara Üniversitesi Eczacılık Fakültesi Dergisi, 15(1), 69-78 (1985).

[77] ŞENER, E., ÖZDEN, S., YALÇIN, İ., ÖZDEN, T. , AKIN, A., YILDIZ, S., 2-(p-Sübstitüe fenil)benzoksazol Türevlerinin Sentez, Yapı Aydınlatması ve Mikrobiyolojil etkileri l-, FABAD Farmasötik Bilimler Dergisi, 11(3), 190-202 (1986).

[78] YALÇIN, İ., ŞENER, E., ÖZDEN, T., ÖZDEN, S., AKIN, A., YILDIZ, S., 5-Kloro-2-(p-Sübstitüe fenil)benzoksazol Türevlerinin Sentez, Yapı Aydınlatması ve Mikrobiyolojik Etkileri II, FABAD Farmasötik Bilimler Dergisi, 11(4), 257-269 (1986).

[79] ÖZDEN, S., ÖZDEN, T., ŞENER, E., YALÇIN, İ., AKIN, A., YILDIZ, S., 5-Nitro-2-(p-Sübstitüe fenil)benzoksazol Türevlerinin Sentez, Yapı Aydınlatması ve Mikrobiyolojik Etkileri, FABAD Farmasötik Bilimler Dergisi, 12(1), 39-47 (1986).

[80] YALÇIN, İ., ŞENER, E., ÖZDEN, S., AKIN, A., YILDIZ, S., 2-(p-Sübstitüe fenil)oksazolo(4,5-b)piridin Türevlerinin Streptococcus faecalis ve Staphylococcus aereus’a Karşı Antibakteriyal Etkileri ve Kantitatif Yapı-Etki İlişkileri, FABAD Farmasötik Bilimler Dergisi, 12(3), 213-222 (1987).

[81] ŞENER, E., YALÇIN, İ., E., ÖZDEN, S., ÖZDEN, T., The Quantitative Structure-Activity relationships of Antibacterial Active 2-(p-Substitutedphenyl)benzoxazole derivatives Against Gram (-) Bacteria Using The Combinations of Some Hydrophobic, Electronic and Steric Paramaters, Gazi Üniversitesi Eczacılık Fakültesi Dergisi, 3(2), 133-142 (1986).

[82] YALÇIN, İ., ŞENER, E.,., ÖZDEN, S., ÖZDEN, T., The Quantitative Structure-Activity relationships of Antibacterial Active 2-(p-Substitutedphenyl)benzoxazole Derivatives Against Candida albicans Using The Combinations of Some Hydrophobic, Electronic and Steric Paramaters, Ankara Üniversitesi Eczacılık Fakültesi Dergisi, 16(1), 24-30 (1986).

[83] YALÇIN, İ., ŞENER, E., E., ÖZDEN, S., ÖZDEN, T., The Quantitative Structure-Activity relationships of Antibacterial Active 2-(p-

Substitutedphenyl)benzoxazole Derivatives Against Gram (+) Bacteria Using The Combinations of Some Hydrophobic, Electronic and Steric Paramaters, FABAD Farmasötik Bilimler Dergisi, 12(1), 48-55 (1987).

[84] ŞENER, E., YALÇIN, İ., ÖZDEN, S., ÖZDEN, T. , AKIN, A., YILDIZ, S., The Antifungal Activity of 2-(p-Substitutedphenyl)oxazolo(4,5-b)pyridine Derivatives Against Candida albicans and The Quantitative Structure-Activity Relationships, FABAD Farmasötik Bilimler Dergisi, 12(4), 281-288 (1987).

[85] ŞENER, E., YALÇIN, İ., E., ÖZDEN, S., ÖZDEN, T. , AKIN, A., YILDIZ, S., Synthesis and Antimicrobial Activities of 5-Amino-2-(p-substitutedphenyl)-benzoxazole Derivativies, Doða Türk Tıp ve Eczacılık Dergisi, 11(3), 391-396 (1987).

[86] ŞENER, E., YALÇIN, İ., AKIN, A., NOYANALPAN, N., Antifungal Activity of 2-Benzylbenzoxazole Derivativies and QSAR’s by Free-Wilson Analysis, Gazi Üniversitesi Eczacılık Fakültesi Dergisi, 4(1), 1-9 (1987).

[87] YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., AKIN, A., YILDIZ, S., The Antibacterial Activity of 2-Phenyloxazolo(4,5-b)pyridine Derivatives Against Gram(-) Bacteria and The Quantitative Structure-Activity Relationships, FABAD Farmasötik Bilimler Dergisi, 13(3), 441-449 (1988).

[88] ŞENER, E., TEMİZ, Ö., ÖREN, İ., YALÇIN, İ., AKIN, A., UÇARTÜRK, N., Synthesis, Antibacterial Activity and QSARs of Some 5-Substituted-2-(p-substitutedbenzyl)benzoxazoles Using The Free-Wilson Analysis, Ankara Üniversitesi, Eczacılık Fakültesi Dergisi, 24(1), 10-20, (1995).

B- DERLEME YAYINLARI [89] BÜYÜKBINGÖL, E., ŞENER, E., Medisinal Kimya Kavramı Içinde Yapı-Etki

Ilişkilerinin Anlamı, Pharmacia-Türk Eczacılar Birliği Dergisi, 24: 52(2), 126-133, (1984).

[90] YALÇIN, İ., ŞENER, E., Selektif Antienflamatuvar Etkili Nonasidik Poliaril Yapıdaki Heterosiklik Bileşiklerin Yapı-Etki İlişkileri, FABAD Farmasötik Bilimler Dergisi, 10(3), 183-194 (1985).

[91] ŞENER, E., YALÇIN, İ., Histaminin Enflamasyondaki Rolü, Antihistaminik Bileşiklerin Enflamasyona Karşı ve Antienflamatuvar Bileşiklerin Histamine Karşı Etkileri, Ankara Eczacı Odası Bülteni, 8(2),99-110 (1986).

[92] YALÇIN, İ., ŞENER, E., Kinazolinon Yapısındaki Antienflamatuvar, Analjezik ve Antipiretik Etkili Bileşikleri Araştırma, Geliştirme Çalışmaları, Ankara Eczacı Odası Bülteni, 8(4), 269-276 (1986).

[93] Ö TEMİZ, Ö., ŞENER, E., Microbiological Activity Benzoxazole, Benzimidazole, Benzothiazole ve Oxazolo(4,5-b)pyridine Derivatives, J. of Ankara University Faculty of Pharmacy, 21(1-2), 36-52, (1992).

[94] Ö TEMİZ, Ö., ŞENER, E., Yeni Geliştirilen Benzodiazepin Türevleri ve Biyolojik Etkileri, Ankara Üniversitesi, Eczacılık Fakültesi Dergisi, 23(1-2), (1994).

[95] YALÇIN, İ., ŞENER, E., Türkiye İlaç Endüstrisinde Özgün İlaç Etken Maddesi Tasarım ve Geliştirilmesi Çalışmalarının Önem ve Gereksinimi., İlaç ve Kimya Endüstrisi İşverenler Sendikası Yayını, Aylık Rapor Sayı:99-100-101, s. 4-5 (1996).

[96] ALPER, S., TEMİZ-ARPACI, Ö., AKI-ŞENER, E., YALÇIN, İ.,”Some New bi-and ter-benzimidazole Derivatives as Topoisomerase I Inhibitors”, Il Farmaco, 58, 497-507, (2003).

C - BASILMIŞ KİTAPLARI [1] ESİN AKI-ŞENER, İSMAİL YALÇIN, , “Farmasötik/Medisinal Kimya’da İlaç

Etken Madde Tasarım Yöntemleri-I, Kantitatif Yapı-Etki İlişkileri Analizleri (QSAR)”, Ankara Üniversitesi, Eczacılık Fakültesi Yayınları No:86, ISBN 975-482-585-8, Ankara Üniversitesi Basımevi, 2003, 323 Sayfa.

[2] “Farmasötik Kimya Pratikleri 1-2” Ankara Üniversitesi Basımevi,2004, ISBN 975-482-649-8, 18 Yazarlı

[3] “Farmasötik Kimya Pratikleri 3-4” Ankara Üniversitesi Basımevi,2004, ISBN 975-482-668-4, 18 Yazarlı

[4] "QSAR & Molecular Modelling in Rational Design of Bioactive Molecules, Proceeding Book of the 15th European Symposium on Structure-Activity Relationships (QSAR) and Molecular Modelling", Esin AKI (SENER) and Ismail YALCIN (Eds.), printed by Başkent Publishing, ISBN 975-00782-0-9, 2006.

D- BİLDİRİLER

D.1. SÖZLÜ BİLDİRİLER 1. YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., Candida albicans’a Karşı Etkili 5-Nitro-2-

(p-substitüefenil)benzoksazol Türevlerinin Kantitatif Yapı-Etki Ilişkileri, Kimya ve Kimya Mühendisliği Sempozyumu, Ankara, Özet Kitabı S:68, 17-20 Eylül 1986.

2. YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., Gram(-) Bakterilere KarŞı Antibakteriyel Etkili 2-(p-sübstitüefenil)benzoksazol Türevleri Üzerinde Kantitatif Yapı-Etki IliŞkileri, Kimya ve Kimya Mühendisliği Sempozyumu, Ankara, Özet Kitabı S:69, 17-20 Eylül 1986.

3. ŞENER, E., YALÇIN, İ., SUNGUR, E., Ilaç Tasarımında Bilgisayar Kullanımı. Antifungal Etkili Benzoksazol ve Oksazolo(4,5-b)piridin Türevlerinin Hansch Analizleri Yardımı ile Kantitatif Yapı-Etkileri , Tıpta Bilgisayar Uygulamaları Sempozyum II, Izmir, 26-29 Eylül 1988.

4. YALÇIN, İ., ŞENER, E., Ilaç Tasarımında Bilgisayar Uygulamalı Kantitatif Yapı-Etki Ilişkisi Tayini. Antibacteriyal Etkili Benzoksazol Türevlerinin Free-Wilson Analizi, Tıpta Bilgisayar Uygulamaları Sempozyumu II, Izmir, 26-29 Eylül 1988.

5. ŞENER, E., YALÇIN, İ., SUNGUR, E., Kantitatif Yapı-Etki İlişkileri Analizi Yardımı ile Bir İlaç Etken Madde Tasarım Çalışmaları, Uluslararası Katılımlı I. Eczacılık Bilimleri Sempozyumu, Özet Kitabı S11, 21-23 Haziran 1989.

6. ŞENER, E., TEMİZ, Ö., ÖREN, İ., YALÇIN, İ., ALTANLAR, N., Synthesis and QSAR Analysis of Some Novel 2,5-Disubstituted Benzoxazoles Against B. subtilis., Second International Meeting on Pharmacy and Pharmaceutical Sciences, İstanbul, Turkey, Abstracts O9, 06-09 September 1998.

7. ŞENER, E., ÖREN, İ., TEMİZ-ARPACI, Ö., BİNGÖL, K. K., YALÇIN, İ., QSARs of Some Novel Antibacretial Active Isosteric Heterocyclics Against Bacillus Subtilis., 2nd International Symposium on Pharmaceutical Chemistry, Ankara, Turkey, Abstract O-23, 22-24 September 1999.

8. ŞENER, E., ÖREN, İ., ARPACI-TEMİZ, YALÇIN, i., “3-D QSAR of Some Antibacterial Active Heterocyclic Compounds Using the CoMSIA Method” 6th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, Abstracts 136, 27-29 September 2000.

9. YALÇIN, İ.; ŞENER, E., ARPACI-TEMİZ, Ö., Tekiner, B. “3-D QSAR of Some Antibacterial Active Heterocyclics Using the CoMSIA Method” 3rd International Symposium on Pharmaceutical Chemistry, Istanbul, Turkey, Abstracts 90, 17-19 September 2001.

10. AKI-ŞENER, E., YALÇIN, İ., YILDIZ, İ., TEMİZ-ARPACI, Ö., ALPER, S., ZAFER, B., “Studies on Pharmacophore Group Identification of Topoisomerase II Inhibitory Active Fused Heterocyclics Using CATALYST HipHop”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 19, 13-14 May, 2005.

11. LAGE, H., AKI-ŞENER, E., YALÇIN, İ., “High Antineoplastic Efficiency of Heterocyclic DNA Topoisomerase II Inhibitors in Classical and Atypical Multidrug-Resistant Cancer Cells”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 25, 13-14 May, 2005

12. KERBOEUF, D., KOCH, C., GUEGNARD, F., TEKİNER-GULBAS, B., AKI-ŞENER, E., YALÇIN, İ., “Some Fused Heterocyclic Compounds as Anthelmintic against Haemonchus conttortus, Nematode parasite of Ruminants”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 37, 13-14 May, 2005.

13. AKI-ŞENER, E., YALÇIN, İ., YILDIZ, I., TEMİZ ARPACI, Ö., ZAFER, B., TEKİNER-GÜLBAŞ; B., “3D-QSAR Studies of Topoisomerase II Inhibitors Using Catalyst ” Watoc`05, Modelling Structure and Reactivity 7th Congress of the World Association of Theoretically Oriented Chemists, Cape Town, South Africa, Abstract C12-5, 16-21 January 2005.

14. YILDIZ, I., YALÇIN, İ., AKI-ŞENER, E., TEMİZ ARPACI, Ö., TEKİNER-GÜLBAŞ; B., “3D-QSAR Studies on Some Topoisomerase II Inhibitors” 3rd International Symposium Computational Methods In Toxicology &Pharmacology Integrating Internet Resources (CMTPI-2005), Shanghai, P.R: China, Abstract ORB-06, October 29th- November 1st, 2005.

15. YALÇIN, İ., AKI-ŞENER, E., YILDIZ, İ. “Studies on pharmacophore identification of topoisomerase II inhibitors using catalyst HipHop” 18 Conferincia de quimica Santiago de Cuba, Cuba, TM-PO2, Abstract page 6-9 December 2005.

16. TEMİZ ARPACI, Ö., ÖKSÜZOĞLU, e., TEKİNER-GÜLBAŞ; B., ZAFER, B., YILDIZ, I., DİRİL, N., AKI-ŞENER, E., YALÇIN, İ., “Genotoxic activities and QSAR studies of some benzoxazoles and benzimidazoles”, QSAR 2006-12th International Workshop on Quantitative Structure-Activity Relationships in Enviromental Toxicology , Lyon, France, Abstract s O -67 , 8-12 May 2006.

17. YALÇIN, İ., AKI-ŞENER, E., YILDIZ, I., TEMİZ ARPACI, Ö., TEKİNER-GÜLBAŞ; B., “Research results incorporated on COST B16 Action from the year 2003 to 2006”, European Conference on the Reversal of Multidrug Resistance from Bacteria to Cancer Cells and Parasites, Budapest, Hungary, Abstracts OP-04, 22-25 April 2006.

18. AKI-ŞENER, E., YALÇIN, İ., ALPER-HAYTA, S., TEKİNER-GÜLBAŞ; B., TEMİZ ARPACI, Ö., YILDIZ, I., ALTANLAR, N., “Synthesis, antimicrobial activity and QSARs of New Benzoxazine-3-ones”, European Conference on the Reversal of Multidrug Resistance from Bacteria to Cancer Cells and Parasites, Budapest, Hungary, Abstracts OP-10, 22-25 April 2006.

19. PINAR, A., YURDAKUL, P., TEMİZ-ARPACI, O., TEKİNER-GULBAS, B., YILDIZ, I., AKI-SENER, E., YALCIN, İ., İLERİ, O., “Eukaryotic Topoisomerase II activity of some novel fused heterocyclic compounds”, 31st FEBS Congress, İstanbul, Turkey, 24-29 June 2006.

20. TEMİZ ARPACI, Ö., ÖKSÜZOĞLU, e., TEKİNER-GÜLBAŞ; B., ZAFER, B., YILDIZ, I., DİRİL, N., AKI-ŞENER, E., YALÇIN, İ., “Genotoxic activities and QSAR studies of some benzoxazoles and benzimidazoles”, QSAR 2006-12th International Workshop on Quantitative Structure-Activity Relationships in Enviromental Toxicology , Lyon, France, Abstract s O -67 , 8-12 May 2006.

21. YILDIZ, I., ALPER, S., ERTAN, T., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., "Molecular Modeling Studies on Some Eucaryotic Topoisomerase II Enzyme Inhibitor Fused Heterocyclic Compounds", 6th AFMC International Medicinal Chemistry Symposium, Istanbul-TURKEY, July 08-11, 2007.

22. AKI, E., “Rasyonel İlaç Tasarım Yöntemleri”, 13. Biyomedikal Mühendisliği Ulusal Toplantısı, Ankara, Türkiye, 29-31 Mayıs, 2008.

23. AKI, E., “General Aspects of Drug Design”, International Seminar on Pharmaceutical Education and Research”, Kashipur, India, p. 21, 23 Feb 2010.

24. YALCIN, I., AKI, E., YILDIZ, O., TEMIZ-ARPACI, O., “Antimicrobial Activity and Structure-Activity Relationships of Some Synthesized Benzazoles and Their Possible Metabolites”, Medicinal Chemistry Research, 19 (Suppl. 1), S41, 2010.

25. AKI, E., YALCIN, I., YILDIZ, I., ERTAN-BOLELLI, T., BOLELLI, K., TASKIN, T., YILMAZ, S., “Kemoterapötik Etkili Bileşiklerin Bilgisayar Destekli İlaç Tasarım Çalışmaları”, 25. Uluslararası Katılımlı Ulusal Kimya Kongresi, IL-009, Sayfa 43, Erzurum, Türkiye, 18-22 Mayıs 2011.

26. AKI, E., İsmail Yalçın, İlkay Yıldız, Betül Tekiner-Gülbaş, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yılmaz, Sanaz Ataei, Özüm Öztürk, Chemometrics in Drug Design, NTCA-2011, 08-11 October 2011, Antalya IL-05: p7.

27. AKI, E., Tugba Taskin, Serap Yilmaz, Tugba Ertan-Bolelli, Kayhan Bolelli, Ozum Ozturk, Ilkay Yildiz, Ismail Yalcin, Yaman Musdal, Yasemin Aksoy. Molecular Modelling Studies on the Design of Chemotherapeutically Active Heterocyclic Compounds, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-1: p26.

28. AKI, E., TUGBA TASKIN, YAMAN MUSDAL, YASEMIN AKSOY, SERAP YILMAZ, TUĞBA ERTAN-BOLELLI, KAYHAN BOLELLI, ILKAY YILDIZ, ISMAIL YALCIN. Docking Studies of GST Inhibitory Active 2-Substituted Benzazoles, 6th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources. 3-7 September 2011, Maribor, Slovenia, Major Talk p.43.

29. TASKIN-TOK, T., AKI, E., YALCIN, I., YILDIZ, I., ERTAN-BOLELLI, T., BOLELLI, K.,

YILMAZ, S., “Docking Studies of Topoisomerase II Inhibitors”, 25. Uluslararası Katılımlı Ulusal Kimya Kongresi, MS-013, Sayfa 180, Erzurum, Türkiye, 18-22 Mayıs 2011.

30. TEMEL, E., BÜYÜKGÜNGÖR, O., CEYLAN, B., YILMAZ, S., YILDIZ, I., YALÇIN, I., AKI, E., “(E)-2-(4’-Klorofenil)-5(2’’-hidroksibenzilidenamino) benzoksazol Bileşiğinin Sentezi, Antimikrobiyal Etki Çalışması ve Moleküler Özelliklerinin Tek Kristal X-Işını Kırınımı Metodu ve Kuramsal Yöntemle İncelenmesi”, SP-017, Sayfa 180, Erzurum, Türkiye, 18-22 Mayıs 2011.

31. ISMAIL YALCIN, KAYHAN BOLELLI, SERAP YILMAZ, ILKAY YILDIZ, AKI, E., Common Feature Pharmacophore Generation of Heterocyclic Compounds Against Efflux pump Over-expressor Bacteria, 6th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources. 3-7 September 2011, Maribor, Slovenia, p.67.

32. ISMAIL YALCIN, AKI, E., ILKAY YILDIZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ. QSAR and Molecular Modeling Studies on Chemotherapeutic Active Benzazoles. AIMECS11 29 November-2 December 2011 Tokyo, IL-B1:p8.

33. AKI, E., İSMAIL YALÇIN, ILKAY YILDIZ, TUĞBA TAŞKIN, TUĞBA ERTAN-BOLELLI, SERAP YILMAZ, KAYHAN BOLELLI, Structure Based Drug Design Methods, 2nd International Conference on Computation for Science and Technology, 09-11 July 2012, Nigde, Invited Lec-7:p52.

34. ISMAIL YALCIN, AKI, E., ILKAY YILDIZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ. Computational Methods in Rational Drug Design, 2nd International Conference on Computation for Science and Technology, 09-11 July 2012, Nigde, Plenary Lec-5:p43.

35. ESIN AKI-YALCIN, ISMAIL YALCIN, ILKAY YILDIZ, TUĞBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, ÖZÜM ÖZTÜRK. Chemometrics in Drug Design, 2st International Conference on New Trends in Chemometrics and Applications (NTCA-2013), Ankara University, Faculty of Pharmacy, Ankara, Turkey, IL-05: p7, 25-28 October 2013.

36. ESIN AKI-YALCIN, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, OZUM OZTURK, TUGBA TASKIN-TOK, ILKAY YILDIZ AND ISMAIL YALCIN. Rational Design of DNA-Topoisomerase Inhibitory Active Benzazoles as Antitumoral Agents, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, O-37: p54, 15-18 October 2013.

37. ISMAIL YALCIN, KAYHAN BOLELLI, SERAP YILMAZ, TUGBA ERTAN-BOLELLI, OZUM OZTURK, SANAZ ATAEI, ILKAY YILDIZ, ESIN AKI-YALCIN. CADD Studies on Chemotherapeutical Active Fused Heterocyclic Compounds, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, S18-01: p55, 15-18 October 2013.

38. ESIN AKI, TUGBA TASKIN, SERAP YILMAZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, ILKAY YILDIZ, ISMAIL YALCIN, YAMAN MUSDAL, YASEMIN AKSOY. Molecular Modelling Studies on the Design of Chemotherapeutically

Active Heterocyclic Compounds, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-1: p26.

39. ISMAIL YALCIN, SERAP YILMAZ, KAYHAN BOLELLI, TUGBA ERTAN-BOLELLI, ILKAY YILDIZ, ESIN AKI-YALCIN. Common Feature Pharmacophore Generation of Heterocyclic Compounds as Bacterial RND Efflux Pump Inhibitors, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-2: p27.

40. Esin AKI-YALÇIN, Ilaç Tasarımında Moleküler Modelleme Yöntemleri, İalç Araştırmalarında Uygulamalı Moleküler modelleme ve Simulasyon Teknikleri Kursu, 20-22 Şubat 2013, Hacettepe Üniversitesi.

41. ESIN AKI-YALCIN, TUGBA TASKIN-TOK, TUGBA ERTAN-BOLELLI, ILKAY YILDIZ, ISMAIL YALCIN. Molecular Docking Analysis of Benzothiazole derivatives as human DNA topoisomerase II inhibitors, Seventh International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2013), Seoul, South Korea, IS-09: p39, 8-12 October 2013.

42. ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, YAMAN MUSDAL, KAYHAN BOLELLI, SERAP YILMAZ, YASEMIN AKSOY, BENGT MANNERVIK, ILKAY YILDIZ, ESIN AKI-YALCIN. Computer Aided Molecular Modeling of the Binding Site and GSH Conjugation Features of the New Human GST P1-1 Inhibitors, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, PL-03: p6, 23-25 September 2014.

43. ESIN AKI-YALCIN, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, OZUM OZTURK, TUGBA TASKIN-TOK, ANDRY NUR HIDAYAT, ILKAY YILDIZ, ISMAIL YALCIN. Anticancer Drug Design Studies using Molecular Modeling Techniques, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, IS-02: p10, 23-25 September 2014.

44. TUGBA ERTAN-BOLELLI, ISMAIL YALCIN, YAMAN MUSDAL, SERAP YILMAZ, KAYHAN BOLELLI, OZUM OZTURK, YASEMIN AKSOY, BENGT MANNERVIK, ILKAY YILDIZ, ESIN AKI-YALCIN. Molecular Docking Studies on Human Glutathione S-transferase Enzyme (hGSTP1-1), The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, O-P13: p28, 23-25 September 2014.

45. SERAP YILMAZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, SANAZ ATAEI, ILKAY YILDIZ, ESIN AKI-YALCIN, ISMAIL YALCIN. Computational Drug Design Studies for Multidrug Resistance AcrAB-TolC Efflux Pump Inhibitors on Escherichia coli, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, O-P106: p62, 23-25 September 2014.

46. ESIN AKI-YALCIN, TUGBA ERTAN-BOLELLI, TUGBA TASKIN-TOK, CIGDEM OZEN, KAYHAN BOLELLI, SERAP YILMAZ, OZUM OZTURK, ILKAY YILDIZ, ISMAIL YALCIN. Identification of Mechanism of Action of DNA-Topoisomerase II Inhibitors by Molecular Modeling Studies, 20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Russia, OC12: p52, 31 August - 4 September 2014.

47. ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, YAMAN MUSDAL, KAYHAN BOLELLI, SERAP YILMAZ, YASEMIN AKSOY, BENGT MANNERVIK, ILKAY YILDIZ, ESIN AKI-YALCIN. Description of the Binding Site Features of Some Fused Heterocycles as New Human GST P1-1 Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-5: p9, 17-19 April 2014.

48. ESIN AKI-YALCIN, TUGBA ERTAN-BOLELLI, TUGBA TASKIN-TOK, SERAP YILMAZ, KAYHAN BOLELLI, OZUM OZTURK, ILKAY YILDIZ AND ISMAIL YALCIN. Molecular Modeling Studies on DNA-Topoisomerase II Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, IL-8: p18, 17-19 April 2014.

49. ILKAY YILDIZ, SANAZ ATAEI, SERAP YILMAZ, TUGBA ERTAN-BOLELLI, EGEMEN FOTO, ESIN AKI-YALCIN, ISMAIL YALCIN. Molecular Modeling Studies On Some Topoisomerase I Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, OP-1: p38-39, 17-19 April 2014.

50. E. AKI-YALCIN, O. OZTURK, T. ERTAN-BOLELLI, K. BOLELLI, S. YILMAZ, A. H. NUR, O. BINGOL-OZAKPINAR, AND F. OZDEMIR. Mechanism of Action of Some New

Anticancer Active Neurokinin-1 (NK1) Receptor Antagonists, 10th AFMC International Medicinal Chemistry Symposium (AIMECS 2015), International Convention Center Jeju, Jeju, Korea, OP4-4: p256, 18-21 October 2015.

51. ISMAIL YALCIN, SERAP YILMAZ, GULSEN ALTINKANAT-GELMEZ, KAYHAN BOLELLI, DENIZ GUNESER-MERDAN, M. UFUK OVER-HASDEMIR, ESIN AKI-YALCIN. Binding Site Description Of Benzothiazoles As the RND Efflux Pump Acrb Inhibitors, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-14: p30, 1-3 October 2015.

52. ESIN AKI-YALCIN, OZUM OZTURK, KAYHAN BOLELLI, TUGBA ERTAN-BOLELLI, ANDRY NUR HIDAYAT, OZLEM BINGOL-OZAKPINAR, FILIZ OZDEMIR, ISMAIL YALCIN. Mechanism of Action of Neurokinin-1 Receptors as an Anticancer Target, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-22: p39-40, 1-3 October 2015.

53. ISMAIL YALCIN, SERAP YILMAZ, KAYHAN BOLELLI, OZUM OZTURK, TUGBA ERTAN-BOLELLI, ESIN AKI-YALCIN. Description of the Binding Site Features of AcrAB-TolC Efflux Pump Inhibitors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, MT-11: p44, 21-25 June 2015.

54. ESIN AKI-YALCIN, OZUM OZTURK, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, A.H. NUR, S. SAHIN, ISMAIL YALCIN, OZLEM BINGOL-OZAKPINAR, FILIZ OZDEMIR. Molecular Modeling Studies on Neurokinin 1 (NK1) Receptors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, MT-12: p47, 21-25 June 2015.

55. ANDRY NUR HIDAYAT, ESIN AKI-YALCIN, ISMAIL YALCIN, MERAL BEKSAC, ERMING TIAN, SAAD Z. Usmani. Docking Study of Human Protease Activated Receptor 1 (PAR1) Antagonists, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, OC-28: p53, 21-25 June 2015.

56. ESIN AKI-YALCIN, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, SERAP YILMAZ, KAYHAN BOLELLI, ÖZÜM ÖZTÜRK, TUGBA TASKIN-TOK, EMINE ÖKSÜZOGLU, CIGDEM ÖZEN-KAPLAN. Computer aided drug design studies for new anticancer drugs, EACR-Sponsored 3rd Anticancer Agent Development Congress, Dokuz Eylül University, Izmir, Turkey, Closing Lecture: p38, 18-19 May 2015.

D.2.POSTER BİLDİRİLERİ

57. ŞENER, E., TURGUT, H., Bazı 5-Sübstitüe-2-(3-piridil)benzoksazol Türevlerinin Sentez, Yapı

Aydınlatması ve Mikrobiyolojik Etkileri, Uluslararası Katılımlı I. Eczacılık Bilimleri Sempozyumu, Ankara, Özet Kitabı P31, 21-23 Haziran 1989.

58. YALÇIN, İ., ŞENER, E., ÖREN, İ., AKIN, A., QSARs of Some Antifungal Active Benzoxazoles and Oxazolo(4,5-b)pyridines by Free-Wilson Analysis, 50th International Congress of F.I.P., Istanbul, Abstracts CS181, 03-07 Eylül 1990.

59. YALÇIN, İ., ŞENER, E., ÖREN, İ., QSARs of Some Antibacterial Active Isosteric Heterosiclic Compounds Against an Enterobacter, 9th European Symposium On Structure-Activity Relationships: QSAR and Molecular Modelling, Strasbourg, France, Abtracts p129, 07-11 Eylül 1992.

60. ŞENER, E., YALÇIN, İ., TEMIZ, Ö., ÖREN, İ., AKIN, A., The Synthesis and Microbioloical Activity of 5-Substituted-2-(p-substitutedbenzyl)benzoxazoles Against An Enteric Gram-Negative Rod, XIIth International Symposium On Medicinal Chemistry, Basel, Switzerland, Abstracts P-005. B, 13-17 Eylül 1992

61. ŞENER, E., TEMİZ, Ö., YALÇIN, İ., ÖREN, İ., AKIN, A., UÇARTÜRK, N., The Synthesis and Microbioloical Activity of 5-Substituted-2-(p-substituted benzyl) benzoxazoles Against Staphylococcus aureus, 3rd International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P20, 15-18 Haziran 1993.

62. YALÇIN, İ., ŞENER, E., ÖREN, İ., TEMİZ, Ö., Determination of the Activity Contributions of Some Novel Isosteric Heterocyclics against an Enteric Gram-negative Rod using the Free-

Wilson Analysis, 10th European Symposium on Structure-Activity Relationships: QSAR and Molecular Modelling, Barcelona, Spain, Abstracts P-169A, 4-9 Eylül 1994.

63. ÖREN, İ., YALÇIN, İ., TEMİZ, Ö., ŞENER, E.,Determination of the Activity Contributions of Some Novel Isosteric Heterocyclics Against a Fungi Candida albicans Using The Free-Wilson Analysis, 4th International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P106, 27-30 Haziran 1995.

64. ŞENER, E., YALÇIN, İ., TEMİZ, Ö., ÖREN, İ., BİNGÖL, K. K., AKIN, A., UÇARTÜRK., The Synthesis and Antimicrobiological Activity of Some 2,5-Disubstituted Benzoxazole and Imidazole Derivatives, 4th International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P109, 27-30 Haziran 1995.

65. WOJCIECHOWSKA, J. K., MROZEK, A., YALÇIN, İ., ŞENER, E., Crystal and Molecular Structure of 5-Chloro-2-(p-ter-buthylphenyl)benzoxazole, 4th International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P113, 27-30 Haziran 1995.

66. WOJCIECHOWSKA, J. K., MROZEK, A., YALÇIN, İ., ŞENER, E., Electronic Conditions For Antimicrobial Activity of 2,5-Disubstituted Benzoxazole Derivatives, 5th International Symposium on Molecular Aspects of Chemotherapy, Gdansk, Poland, Abstracts No 4, pg 44, 21-24 August 1995.

67. YALÇIN, İ., ŞENER, E., ÖREN, İ., Activity Contributions of Some Novel Isosteric Heterocyclics Against Nosocomial Infection Caused Gram-Negative Rod Using The Free-Wilson Analysis, 1995 Gordon Research Conference on Quantitative Structure-Activity Relationships, Tilton, N.H., U.S.A., 6-11 August 1995.

68. ŞENER, E., ÖREN, İ., TEMİZ, Ö. and YALÇIN, İ. “Synthesis and Antimycotic Activity of Some 2, 5, 6-Trisubstituted Benzoxazoles and Benzimidazoles Against C. albicans”, First Italian-Swiss Meeting on Medicinal Chemistry, September 23-26, 1997, Torino, Italy.

69. ŞENER, E., ÖREN, İ., TEMİZ-ARPACI, Ö., BİNGÖL, K. K., YALÇIN, İ., QSARs of Some Novel Antibacterial Benzoxazoles, Benzimidazoles, Benzothiazoles and Oxazolo(4,5-b)pyridines Against S. aureus., 1999 Gordon Research Conference on Quantitative Structure-Activity Relationships, Tilton, N.H., U.S.A., 25-30 July 1999.

70. YALÇIN, İ., ÖREN, İ., TEMİZ-ARPACI, Ö., TEKİNER, B., ŞENER, E., QSARs of Some Novel Antifungal Active Isosteric Heterocyclics, 7th International Symposium on Molecular Aspects of Chemotherapy, Gdansk, Poland, Abstracts No 86, p.165, 08-11 September 1999.

71. YALÇIN, İ., TEKİNER, B., ÖREN, İ., ŞENER, E., TEMİZ-ARPACI, Ö., ALTANLAR, N., Synthesis and Antimicrobial Activity of Some Novel 2,6,7-Trisubstituted-2(H)-3,4-dihidro-1,4-benzoxazine Derivatives., 2nd International Symposium on Pharmaceutical Chemistry, Ankara, Turkey, Abstract P-09, 22-24 September 1999.

72. ŞENER, E., ARPACI, Ö. T., ÖREN, İ., BİNGÖL, K. K., YALÇIN, İ., The QSAR Analysis of Some Novel 2-p-Substituted-phenyl-5-Substitutedcarbonylaminobenzoxazoles Against a Gram-Negative Rod., 6th International Symposium on Pharmaceutical Sciences, Ankara, Turkey., Abstracts P-147 p. 282, 27-29 June 2000.

73. ŞENER, E., ÖREN, İ., ARPACI-TEMİZ, Ö., YALÇIN, İ.; “3-D QSAR of Some Antifungal Active Heterocyclic Compounds Using the CoMSIA Method” 13th European Symposium on Quantitative Structure-Activity Relationships, QSAR 2000 Düsseldorf, Germany, Abstracts P 53, 27 August-1 September 2000.

74. ARPACI-TEMİZ Ö., ŞENER, E., YALÇIN, İ.; TEKİNER, B., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 2,5-Disubstitutedbenzoxazole Derivatives” 3rd International Symposium on Pharmaceutical Sciences, Istanbul, Turkey, Abstracts p. 193, 17-19 September 2001.

75. AKI-ŞENER, E,, ÖREN, I., TEMİZ-ARPACI, O., YALÇIN; I., “3-D QSAR of Some Antifungal Active Heterocyclic Compounds Using the CoMSIA Method” 13th European Symposium on Quantitative Structure-Activity Relationships, QSAR 2000 Düsseldorf, Germany, Abstracts P 53, 27 August-1 September 2000.

76. YALÇIN, I., AKI-ŞENER, E., YILDIZ-ÖREN, I., TEMİZ-ARPACI, O., KOCAGÖZ, T., YURDAKUL; P., “A New Class of Eukaryotic DNA Topoisomerase II Inhibitors”, XVIIth International Symposium on Medicinal Chemistry, Barselona, İspanya, Abstract page 512, 01-05 Eylül 2002.

77. AKI-ŞENER, E., YALÇIN, I., YILDIZ-ÖREN, I., TEMİZ-ARPACI, O., TEKİNER, B.; “3D-QSAR of Some Antibacterial Active Heterocyclics Using The CoMFA Method” Euro QSAR 2002, Bournemouth, Abstracts 098, 8-13 September 2002.

78. YILDIZ-ÖREN, I., TEKİNER, B., TEMİZ-ARPACI, O., YALÇIN, I., AKI-ŞENER; E., “DTF Calculations of Some Antimicrobial Active 1,4-Benzoxazine-3-on Derivatives”, 1st

International Meeting on Medicinal and Pharmaceutical Chemistry, Ankara, Abstract page 123, 25-28 Eylül 2002.

79. Betül TEKİNER, Özlem TEMİZ-ARPACI, İlkay YILDIZ-ÖREN, İsmail YALÇIN, AKI-ŞENER, E., “QSARs of some novel antifungal 5-substituted-2-(p-substitutedbenzyl)benzoxazoles against C. krusei ” 7thInternational Symposium on Pharmaceutical Science, Ankara, Abstracts page 320, 24-27 June 2003.

80. Betül TEKİNER, İsmail YALÇIN, İlkay YILDIZ-ÖREN, Özlem TEMİZ-ARPACI, AKI-ŞENER, E., Nurten ALTANLAR; “ Synthesis and antimicrobial activity of some 2,5-disubstitutedbenzoxazole derivatives against P. Aeruginosa” , 7thInternational Symposium on Pharmaceutical Science, Ankara, Abstracts page 321, 24-27 June 2003.

81. İlkay YILDIZ-ÖREN, Özlem TEMİZ-ARPACI, Betül TEKİNER, AKI-ŞENER, E., İsmail YALÇIN; “3-D QSAR of some microbiological active 2,5-disubstituted-benzoxazoles against S. Aureus using the CoMFA method” , 7thInternational Symposium on Pharmaceutical Science, Ankara, Abstracts page 325, 24-27 June 2003.

82. AKI-ŞENER, E., İsmail YALÇIN, İlkay YILDIZ-ÖREN, Özlem TEMİZ-ARPACI; “3D-QSAR of Some Antifungal Active Benzoxazoles, Benzimidazoles, Benzothiazoles and Oxazolopyridines Using the CoMFA Method”, Bioactive Discovery in the New Millennium, Lorne, Victoria, Avustralya, Abstract P53, 05-09 February 2003.

83. İlkay YILDIZ, Özlem TEMİZ ARPACI, Betül P. TEKİNER-GÜLBAŞ, İsmail YALÇIN, AKI-ŞENER, E., Berk ZAFER “CoMFA and CoMSIA studies of microbiologically active 5-(substituted-carbonylamino)-2-benzylbenzoxazoles” 4thInternational Symposium on Pharmaceutical Chemistry, İstanbul, Abstracts P-128 17-19 September 2003.

84. İlkay YILDIZ-ÖREN, Betül TEKİNER-GÜLBAŞ, Özlem TEMİZ-ARPACI, İsmail YALÇIN, AKI-ŞENER, E., Nurten ALTANLAR; “ Synthesis and antimycotic activity of some new 2-benzyl-5-substituted carboxamidobenzoxazoles against Candida species” Polish-Austrian-German-Hungarian-Italian Joint Meeting on Medicinal Chemistry, Krakow, Poland, Abstract P68, 15-18 October 2003.

85. Özlem TEMİZ-ARPACI, Sabiha ALPER, İlkay YILDIZ-ÖREN, AKI-ŞENER, E., İsmail YALÇIN, Nurten ALTANLAR; “ Synthesis and antimicrobial activity of some new 1,4-benzoxazine-3-one derivatives” Polish-Austrian-German-Hungarian-Italian Joint Meeting on Medicinal Chemistry, Krakow, Poland, Abstract P69, 15-18 October 2003.

86. İsmail YALÇIN, AKI-ŞENER, E., İlkay YILDIZ, Özlem TEMİZ-ARPACI, Betul TEKİNER-GÜLBAŞ “Lead Optimization of some fused isosteric heterocyclic compounds as topoisomerase II inhibitors” Fifth AFMC International Medicinal Chemistry Symposium AIMECS 03, Kyoto, Japan, Abstract B-74, 14-17 October 2003.

87. İlkay YILDIZ, Özlem TEMİZ-ARPACI, Berk ZAFER, Betul TEKİNER-GÜLBAŞ, Sabiha ALPER, AKI-ŞENER, E.,, İsmail YALÇIN, Aslı PINAR, Pınar YURDAKUL, Leyla ACAN “Pharmacophore analysis of some ısosteric fused heterocyclics as topoisomerase II inhibitors” The 15th European Symposium on Quantitative Structure-Activity Relationships & Molecular Modelling, İstanbul, Turkey, Abstract B-18, 05-10 September 2004.

88. Özlem TEMİZ-ARPACI, İlkay YILDIZ, AKI-ŞENER, E.,, İsmail YALÇIN, Betul TEKİNER-GÜLBAŞ, Sabiha ALPER, Berk ZAFER, Emine Öksüzoğlu, Nuran Diril “ 2D-QSAR studies of some benzoxazoles and benzimidazoles” The 15th European Symposium on Quantitative Structure-Activity Relationships & Molecular Modelling, İstanbul, Turkey, Abstract B-19, 05-10 September 2004.

89. YILDIZ, İ., TEMİZ-ARPACI, Ö., TEKİNER-GÜLBAŞ, B., ERTAN, T., AKI-ŞENER, E.,, YALÇIN, I., “COMFA 3D-QSAR Studies on benzazole derivatives as eukaryotic topoisomerase II inhibitors” Joint Meeting on Medicinal Chemistry, Vienna, Austria, June 20-23, 2005 Scientia Pharmaceutica Supplement 1. 73(2) S234, 2005.

90. TEMİZ-ARPACI, O., TEKİNER-GÜLBAŞ, B., YILDIZ, I., AKI-ŞENER, E., YALÇIN, I., ALTANLAR; N., “Synthesis and antifungal activity of some new 5-ethylsulphonyl-2-substitutedbenzoxazoles” Joint Meeting on Medicinal Chemistry, Vienna, Austria, June 20-23, 2005 Scientia Pharmaceutica Supplement 1. 73(2) S235, 2005.

91. ZEYBEK, B., DURMUŞ, z., TEKİNER-GÜLBAŞ, B., AKI-ŞENER, E., YALÇIN, İ., KILIÇ, E. “Bazı Benzoksazol Türevlerinin Elektrokimyasal Davranışlarının İncelenmesi” XIX. Ulusal Kimya Kongresi, AKP 72, 30 Eylül-4 Ekim 2005, Kuşadası.

92. ERTAN, T., YILDIZ, I., BOLELLI, K., TEMİZ-ARPACI, O., TEKİNER-GÜLBAŞ, B., AKI-ŞENER, E., YALÇIN, I., ABBASOGLU; U., “Synthesis and antibacterial activity of some 4-substituted-N-(2-hydroxy-5(or 6)-nitrophenyl)benzamide derivatives” International Symposium

on Medicinal Chemistry Research and Development Kusadasi, Turkey, Abstract P81, September 28-October 1, 2005,.

93. ALPER-HAYTA S., YILDIZ, I., AKI-SENER E., TEMİZ-ARPACI O., YALCİN I., “ QSAR of some antimicrobial 1,4-benzoxazine-3-one derivatives against C. krusei”, 8thInternational Symposium on Pharmaceutical Science, Ankara, Abstracts page 307, P-189, 13-16 June 2006.

94. YILDIZ, I., AKI-SENER, E., YALCIN, I., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., “3D-QSAR CoMSIA Study on Heterocyclic Topoisomerase II Inhibitors”, The 16th European Symposium on Quantitative Structure-Activity Relationships & Molecular Modelling, Mediterranean Sea, Italy, Abstract page 223, 10-17 September 2006.

95. BOLELLİ, K., YALCIN, I., ERTAN, T., KAYNAK-ONURDAG, F., YILDIZ, I., TEMIZ-ARPACI, I., AKI-SENER, E., ABBASOGLU, U., "Synhtesis, Structure Elucidation and Microbiological Activity of Some New 2-[4-(4-Substitutedbenzamido)phenyl]benzothiazole Derivatives", Abst. P-61, 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-3), Antalya-TURKEY, October 16-21, 2007.

96. ALPER-HAYTA, S., ARISOY, M., TEMIZ-ARPACI, O., YILDIZ, I., AKI-SENER, E., KAYNAK-ONURDAG, F., "Synthesis and Antimicrobial Activity of Some New N-(2-Substitutedbenzoxazol-5-yl)-2-benzofurancarboxamides", Abst. P-11, 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-3), Antalya-TURKEY, October 16-21, 2007.

97. ARISOY, M., TEMIZ-ARPACI, O., KAYNAK-ONURDAG, F., YILDIZ, I., AKI-SENER, E., YALCIN, I., ABBASOGLU, U., "Synthesis and Antimicrobial Activity of Some Novel 2-(p-Substitutedbenzyl)-5-(2-substitutedacetamido)benzoxazole Derivatives", Abst. P-24, 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-3), Antalya-TURKEY, October 16-21, 2007.

98. S. ALPER-HAYTA, I. YILDIZ, O. TEMIZ-ARPACI, AKI-ŞENER, E.,, I. YALCIN. Free-Wilson Study on some microbiologically active benzazoles. CMPTI-2007,Moscow, Russia, Sept. 01-05, 2007 (Abstract PO4).

99. I. YALCIN, AKI-ŞENER, E., I. YILDIZ, O. TEMIZ-ARPACI, B. ZAFER, B. TEKINER-GULBAS, S. ALPER. Pharmacophore Analysis of topoisomerase II inhibitory active benzazoles.CMPTI-2007,Moscow, Russia, Sept. 01-05, 2007 (MT-17).

100. ARISOY, M., TEMIZ-ARPACI, O., KAYNAK-ONURDAG, F., YILDIZ, I., AKI-SENER, E., YALCIN, I., ABBASOGLU, U., "Synthesis and Antimicrobial Activity of Some Novel N-(2-Substitutedbenzoxazol-5-yl)-2-(4-substitutedpiperazin-1-yl)acetamides", Abst. PC-29, 6th AFMC International Medicinal Chemistry Symposium (AIMECS 07), Istanbul-TURKEY, July 08-11, 2007.

101. TEMIZ-ARPACI, O., ARISOY, M., KAYNAK-ONURDAG, F., YILDIZ, I., AKI-SENER, E., YALCIN, I., ABBASOGLU, U., “Synthesis and antimicrobial activity of some novel N-[2-p-substitutedbenzyl/phenyl-5-benzoxazolyl)]-2-morpholinoacetamides”, 4th central European conference chemistry towards biology, Dobogo’ko’’, Hungary, Sept. 8-11, 2008 (Abstract P63).

102. YILDIZ, I., ERTAN, T., BOLELLİ, K., TEMİZ-ARPACI, O., YALCIN, I., AKI-SENER, E., “ Molecular modeling studies on some benzoxazoles as eukaryotic DNA Topoisomerase II inhibitors”, 4th central European conference chemistry towards biology, Dobogo’ko’’, Hungary, Sept. 8-11, 2008 (Abstract P135).

103. 1- YILDIZ, İ., ATEİ, S., YILMAZ, S., FOTO, E., ERTAN-BOLELLİ, T., BOLELLİ, K., DİRİL, N., AKI, E., YALCIN. İ., “Three-Dimensional Common-Feature Hypotheses on Benzoxazine Derivatives as Topoisomerase I Inhibitors”, 18th International Conference on Organic Synthesis, Bergen, Norway, August 1-6, 2010, P:377.

104. YILMAZ, S., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-Benzotiyazol Türevlerinin 1H-Nükleer Manyetik Rezonans Spektrum Analizleri ile Yapılarının Aydınlatılması”, P-212, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

105. TEMEL, E., BÜYÜKGÜNGÖR, O., CEYLAN, B., YILMAZ, S., YILDIZ, I., YALÇIN, I., AKI, E., “(E)-2-(4’-Klorofenil)-5(2’’-hidroksibenzilidenamino) benzoksazol Bileşiğinin Sentezi, Antimikrobiyal Etki Çalışması ve Moleküler Özelliklerinin Tek Kristal X-Işını Kırınımı Metodu ve Kuramsal Yöntemle İncelenmesi”, SP-017, Sayfa 180, Erzurum, Türkiye, 18-22 Mayıs 2011.

106. İLKAY YILDIZ, SERAP YILMAZ, SANAZ ATAEI, AKI, E., İSMAIL YALÇIN.Pharmacophore Analysis of Some Aromathecins as Topoisomerase I Inhibitor, NTCA-2011, 08-11 October 2011, Antalya PP-36: p63.

107. KAYHAN BOLELLI, SERAP YILMAZ, İSMAIL YALÇIN, İLKAY YILDIZ, AKI, E, QSAR Analysis of Some 2-Substituted Benzothiazoles as Antibacterial Agents against Multidrug-Resistant Staphylococcus aureus, NTCA-2011, 08-11 October 2011, Antalya PP-37: p64.

108. SERAP YILMAZ, İLKAY YILDIZ, AKI, E., İSMAIL YALÇIN.3D Pharmacophore Modelling of Some Fused Heterocyclic compounds as Topoisomerase II Inhibitor, NTCA-2011, 08-11 October 2011, Antalya PP-38: p65.

109. TUGBA ERTAN-BOLELLI, İLKAY YILDIZ, SELDA ÖZGEN, ESIN AKI, İSMAIL YALÇIN. QSAR Analysis of Some Novel 2-(p-Substitutedphenyl/benzyl)-5-(p-substitutedbenzensulfonamido) benzoxazoles against Mycobacterium tuberculosis isolate, NTCA-2011, 08-11 October 2011, Antalya PP-39: p66.

110. BOLELLİ, K., ERTAN-BOLELLI, T., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-[4-(4-Sübstitüebenzamido)fenil]benzotiyazol Türevlerinin 1H-NMR Spektroskopi Çalışmaları”, P-210, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

111. YILMAZ, S., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-Benzotiyazol Türevlerinin 1H-Nükleer Manyetik Rezonans Spektrum Analizleri ile Yapılarının Aydınlatılması”, P-212, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

112. YILDIZ, I., ERTAN, T., BOLELLİ, K., TEMİZ-ARPACI, O., YALCIN, I., AKI, E., “ Molecular modeling studies on some benzoxazoles as eukaryotic DNA Topoisomerase II inhibitors”, 4th central European conference chemistry towards biology, Dobogo’ko’’, Hungary, Sept. 8-11, 2008 (Abstract P135).

113. YILDIZ, I., ATAEI, S., YILMAZ, S., AKI, E., YALCIN, I. “Study on molecular modeling of some topoisomerase I inhibitors” P-19, 11th International Nutrition&Diagnostics Conference INDC 2011, Brno, Czech Republic, August 28-31, 2011.

114. TUGBA ERTAN-BOLELLI, İLKAY YILDIZ, SELDA ÖZGEN, AKI, E, ISMAIL YALCIN. Docking Studies of Enoyl-ACP Reductase Enzyme Inhibitors, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO98:p161.

115. KAYHAN BOLELLI, TUGBA ERTAN-BOLELLI, OZUM OZTURK, ILKAY YILDIZ, AKI,

E., ISMAIL YALCIN. Docking Studies of Some Fused Heterocyclic Compounds into HIV-1 Reverse Transcriptase Enzyme, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO95:p158.

116. AKI, E., TUGBA TASKIN, ISMAIL YALCIN, YAMAN MUSDAL, YASEMIN AKSOY, SERAP YILMAZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, İLKAY YILDIZ. Computational Drug Design Studies of Some new GST Inhibitory Active 2-Substituted Benzoxazoles and Benzothiazoles, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO93:p156

117. KAYHAN BOLELLI, SERAP YILMAZ, ILKAY YILDIZ, AKI, E., ISMAIL YALCIN. Common Feature Pharmacophore Generation of Bacterial AdeABC Efflux Pump Inhibitors, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO78:p141.

118. SERAP YILMAZ, SANAZ ATAEI, ILKAY YILDIZ, AKI, E., ISMAIL YALCIN. Pharmacophore Modelling of Some Fused Heterocyclic Compounds as HIV-1 Reverse Transcriptase Inhibitors, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO83:p146.

119. SANAZ ATAEI, SERAP YILMAZ, ILKAY YILDIZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, AKI, E, ISMAIL YALCIN. Common Feature Pharmacophore Generation of DNA Topoisomerase II Enzyme Inhibitors, 49th International Conference on Medicinal Chemistry (RICT-49), The Conference Center Nice Acropolis, Nice, France, HT006: p182), 3-5 July 2013.

120. OZUM OZTURK, AKI, E, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, SANAZ ATAEI, ILKAY YILDIZ, ISMAIL YALCIN. Common Feature Pharmacophore Generation of DNA Topoisomerase II Enzyme Inhibitors, 49th International Conference on Medicinal Chemistry (RICT-49), The Conference Center Nice Acropolis, Nice, France, HT094: p268, 3-5 July 2013.

121. SERAP YILMAZ, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, ILKAY YILDIZ, AKI, E. Molecular Modeling and Docking Studies of AcrB Trimeric Multidrug Efflux Pumps, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P11: p63.

122. OZUM OZTURK, AKI, E, Tuğba Ertan-Bolelli, Kayhan Bolelli, Serap Yılmaz, İlkay Yıldız, İsmail Yalçın. Docking Studies of Human Topoisomerase II Enzyme Inhibitors, 1st International

BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P12: p64.

123. KAYHAN BOLELLI, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, SERAP YILMAZ, OZUM OZTURK, ILKAY YILDIZ, AKI, E. Docking Studies of Glutathion S-Transferase (GST) Inhibitors, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P13: p65.

124. J.B. BHAGYASREE, HEMA TRESA VARGHESE, C. YOHANNAN PANICKER, JADU SAMUEL, CHRISTIAN VAN ALSENOY, KAYHAN BOLELLI, ILKAY YILDIZ, AKI, E.,. Vibrational spectroscopic (FT-IR, FT-Raman, 1H NMR and UV) investigations and computational study of 5-nitro-2-(4-nitrobenzyl) benzoxazole, 2st International Conference on New Trends in Chemometrics and Applications (NTCA-2013), Ankara University, Faculty of Pharmacy, Ankara, Turkey, PP-26: p54, 25-28 October 2013.

125. KAYHAN BOLELLI, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, SERAP YILMAZ, OZUM OZTURK, YAMAN MUSDAL, ILKAY YILDIZ AND AKI-YALÇIN, E., Molecular Docking Studies of Glutathion S-Transferase Inhibitors, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, P1-03: p62, 15-18 October 2013.

126. SERAP YILMAZ, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, SANAZ ATAEI, ILKAY YILDIZ, AND AKI-YALÇIN, E.Molecular Docking Studies on AcrB Trimeric Multidrug Efflux Pumps of Escherichia coli, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, P1-04: p63, 15-18 October 2013.

127. TUGBA ERTAN-BOLELLI, ILKAY YILDIZ, SELDA OZGEN, KAYHAN BOLELLI, SERAP YILMAZ, SANAZ ATAEI, OZUM OZTURK, AKI-YALÇIN, E., AND ISMAIL YALCIN. Molecular Docking Studies on Enoyl-ACP Reductase Enzyme, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, P1-05: p63, 15-18 October 2013.

128. KAYHAN BOLELLI, TUĞBA ERTAN-BOLELLI, YAMAN MUSDAL, SERAP YILMAZ, OZUM OZTURK, YASEMIN AKSOY, ILKAY YILDIZ, AKI-YALÇIN, E.ISMAIL YALCIN. Docking Studies on Glutathione S-Transferase P1-1 Enzyme, Seventh International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2013), Seoul, South Korea, PO-C-03: p66, 8-12 October 2013.

129. TUGBA ERTAN-BOLELLI, ILKAY YILDIZ, KAYHAN BOLELLI, SERAP YILMAZ, SANAZ ATAEI, OZUM OZTURK, SELDA OZGEN, AKI-YALÇIN, E., ISMAIL YALCIN. Molecular Docking Studies on Dihydropteroate Synthase Enzyme, Seventh International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2013), Seoul, South Korea, PO-C-09: p72, 8-12 October 2013.

130. SANAZ ATAEI, SERAP YILMAZ, ILKAY YILDIZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, AKI-YALÇIN, E., ISMAIL YALCIN. Common Feature Pharmacophore Generation of DNA Topoisomerase II Enzyme Inhibitors, 49th International Conference on Medicinal Chemistry (RICT-49), The Conference Center Nice Acropolis, Nice, France, HT006: p182, 3-5 July 2013.

131. Ozum OZTURK AKI-YALÇIN, E., Tugba ERTAN-BOLELLI, Kayhan BOLELLI, Serap YILMAZ, Sanaz ATAEI, Ilkay YILDIZ, Ismail YALCIN. Common Feature Pharmacophore Generation of DNA Topoisomerase II Enzyme Inhibitors, 49th International Conference on Medicinal Chemistry (RICT-49), The Conference Center Nice Acropolis, Nice, France, HT094: p268, 3-5 July 2013.

132. Serap YILMAZ, Ismail YALCIN, Tugba ERTAN-BOLELLI, Kayhan BOLELLI, Ozum OZTURK, Ilkay YILDIZ, AKI-YALÇIN, E.. Molecular Modeling and Docking Studies of AcrB Trimeric Multidrug Efflux Pumps, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P11: p63, 21-23 March 2013.

133. OZUM OZTURK, AKI-YALÇIN, E., TUĞBA ERTAN-BOLELLİ, KAYHAN BOLELLİ, SERAP YILMAZ, İLKAY YILDIZ, İSMAIL YALÇIN. Docking Studies of Human Topoisomerase II Enzyme Inhibitors, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P12: p64, 21-23 March 2013.

134. KAYHAN BOLELLI, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, SERAP YILMAZ, OZUM OZTURK, ILKAY YILDIZ, AKI-YALÇIN, E.. Docking Studies of Glutathion S-Transferase (GST) Inhibitors, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P13: p65, 21-23 March 2013.